Efficacy and Safety of Pulsed Low-Dose Rate Radiotherapy in Re-Irradiation of Recurrent Solid Tumors
PLDR re-irradiation demonstrates favorable efficacy and safety in recurrent solid tumors. For recurrent glioma, patients with IDH1 mutation, nontemporal lobe recurrence, and a re-irradiation interval >24 months appear to derive greater benefit from PLDR radiotherapy.
Authors
- Zifang Liu (ORCID: https://orcid.org/0009-0003-4088-1797)
- Hui Qiu (ORCID: https://orcid.org/0000-0002-5819-0965)
- Xin Ding (ORCID: https://orcid.org/0000-0001-7870-0320)
- Huacong Jin
- Wenjing Cao
- Xinyan Zhang
Institutions
- Jiangsu University (CN)
- Xuzhou Medical College (CN)
- Cancer Institute (WIA) (IN)
- Xuzhou Cancer Hospital (CN)
Publication Details
- Journal
- American Journal of Clinical Oncology
- Published
- 2026-03-13
- DOI
- https://doi.org/10.1097/coc.0000000000001317
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00